Open Label Randomized Clinical Study to Promote a Healthy Lifestyle in Medical Students

NCT ID: NCT05073029

Last Updated: 2021-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-10

Study Completion Date

2019-11-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main medical and social purpose of the project "It's trendy to be healthy!" is the promotion of healthy lifestyles and healthy eating among student youth. The relevance of this project is beyond doubt, as the WHO called obesity a non-communicable epidemic, and according to research by the Jane Schiller University of Germany (Germany), as mentioned above, Ukraine topped the list of the countries with high mortality due to malnutrition

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Obesity Nutrition, Healthy Vitamin D Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard care group

3-month course of individually selected nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)

Group Type ACTIVE_COMPARATOR

nutrition program and modification of physical activity

Intervention Type OTHER

nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)

intervention group

additionally to previous group recieved treatment with synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103) and vitamin D3 - 2000 IU. The students were instructed to take vitamin D3 and synbiotic sachets twice a day for 3 months.

Group Type EXPERIMENTAL

synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103, 4.0х109 colony forming units - CFU)

Intervention Type DIETARY_SUPPLEMENT

one synbiotic sachet (3g), BID, for 3 month traetment

vitamin D3

Intervention Type DIETARY_SUPPLEMENT

vitamin D3, oral, 2000IU BID, for 3 month treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nutrition program and modification of physical activity

nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)

Intervention Type OTHER

synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103, 4.0х109 colony forming units - CFU)

one synbiotic sachet (3g), BID, for 3 month traetment

Intervention Type DIETARY_SUPPLEMENT

vitamin D3

vitamin D3, oral, 2000IU BID, for 3 month treatment

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Acidolac Olidetrim

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* medical students aged between 18-25 years;
* presence of presence of vitamin D deficiency or insuficiency (serum total vit D3 level less than );
* signed informed consent.

Exclusion Criteria

* regular intake of probiotics, prebiotics, antibiotics, anticonvulsants, calcium and vit. D supplements for 3 months prior the inclusion;
* previously diagnosed allergy to gut microbiota-based therapy; gastrointestinal disorders including food allergy, gluten-sensitive enteropathy, ulcerative colitis;
* suffering from any psychiatric illness; presence of diabetes mellitus, chronic cardiovascular or respiratory disease, an active malignant tumor or chronic infections; participation in another clinical trial;
* pregnancy or lactation;
* any condition thought to be associated with poor compliance (e.g., alcoholism or drug addiction) or any condition or circumstance that would, in the opinion of the investigator, prevent completion of the study or interfere with analysis of study results.
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taras Shevchenko National University of Kyiv

OTHER

Sponsor Role collaborator

Bogomolets National Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nazarii Kobyliak

Associate Professor, Endocrinology Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nataliia Molochek, PhD

Role: STUDY_DIRECTOR

ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv

Liudmyla Ostapchenko, Professor

Role: STUDY_CHAIR

ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bogomolets National Medical University

Kyiv, , Ukraine

Site Status

Taras Shevchenko National University of Kyiv

Kyiv, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ukraine

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ENDO-7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.